| A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain (NCT06132945) | Memorial Sloan Kettering Cancer Center | 2023-11-10 |
| Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 (NCT06065462) | M.D. Anderson Cancer Center | 2023-11-10 |
| SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus (NCT06144710) | Hangzhou Sumgen Biotech Co., Ltd. | 2023-11-10 |
| A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis (NCT05890729) | Xentria, Inc. | 2023-11-10 |
| Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart (NCT06822153) | Ahon Pharmaceutical Co., Ltd. | 2023-11-09 |
| Evaluate the Safety, Tolerability of BAT6026 (NCT06094179) | Bio-Thera Solutions | 2023-11-09 |
| Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer (NCT06059014) | Centre Leon Berard | 2023-11-09 |
| Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 (NCT06084481) | AbbVie | 2023-11-09 |
| A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer (NCT06075810) | MBQ Pharma | 2023-11-09 |
| Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers (NCT06119945) | Daewoong Pharmaceutical Co. LTD. | 2023-11-09 |
| A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors (NCT06024174) | Bristol-Myers Squibb | 2023-11-09 |
| Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors (NCT05799274) | Radiopharm Theranostics, Ltd | 2023-11-09 |
| GD2-CAR T Cells for Pediatric Brain Tumours (NCT05298995) | Bambino Gesù Hospital and Research Institute | 2023-11-09 |
| Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma (NCT06079164) | Kite, A Gilead Company | 2023-11-09 |
| A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke (NCT06299033) | Hopstem Biotechnology Inc. | 2023-11-09 |
| Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145 (NCT06063343) | Novakand Pharma AB | 2023-11-09 |
| Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants (NCT06133478) | Nuvamid SA | 2023-11-09 |
| Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers (NCT05803382) | National Cancer Institute (NCI) | 2023-11-08 |
| A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024) (NCT06699355) | Merck Sharp & Dohme LLC | 2023-11-08 |
| Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert (NCT06087913) | Eastern Virginia Medical School | 2023-11-08 |
| Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer (NCT05540899) | American College of Radiology | 2023-11-08 |
| A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects (NCT06670898) | Nippon Shinyaku Co., Ltd. | 2023-11-08 |
| A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood (NCT06070610) | Boehringer Ingelheim | 2023-11-08 |
| Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults (NCT06151288) | Vaxcyte, Inc. | 2023-11-08 |
| A Study of GC101 TIL in Advanced Melanoma (BZ) (NCT06120712) | Shanghai Juncell Therapeutics | 2023-11-08 |
| A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors (NCT06238687) | Tasly Pharmaceutical Group Co., Ltd | 2023-11-08 |
| Study Evaluating ISM5411 Administered Orally to Healthy Volunteers (NCT06012578) | InSilico Medicine Hong Kong Limited | 2023-11-08 |
| [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients (NCT06132737) | Pentixapharm AG | 2023-11-07 |
| Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects (NCT06107205) | Shanghai Auzone Biological Technology Co., Ltd. | 2023-11-07 |
| JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors (NCT06108050) | Jazz Pharmaceuticals | 2023-11-07 |
| A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i (NCT05953350) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-11-07 |
| A Study of ST-1898 for Unresectable or Metastatic Melanoma (NCT06359860) | Beijing Scitech-Mq Pharmaceuticals Limited | 2023-11-07 |
| Intratumoral PH-762 for Cutaneous Carcinoma (NCT06014086) | Phio Pharmaceuticals Inc. | 2023-11-07 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants (NCT06122714) | AstraZeneca | 2023-11-07 |
| Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors (NCT06014658) | MBrace Therapeutics | 2023-11-07 |
| A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis (NCT06084988) | Cellcolabs Clinical SPV Limited | 2023-11-07 |
| A Study of the Effect of Nemtabrutinib (MK-1026) on the Plasma Levels of Digoxin in Healthy Participants (MK-1026-012) (NCT06625827) | Merck Sharp & Dohme LLC | 2023-11-07 |
| A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years (NCT05991427) | CanSino Biologics Inc. | 2023-11-07 |
| Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases (NCT06069570) | Kiromic BioPharma Inc. | 2023-11-07 |
| A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors (NCT06126666) | ABL Bio, Inc. | 2023-11-07 |
| A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different Sites (NCT06086912) | Jiangsu HengRui Medicine Co., Ltd. | 2023-11-07 |
| Interferon Alpha Therapy for Cervical CINI and HPV Infection (NCT06137950) | Mongolian National University of Medical Sciences | 2023-11-07 |
| Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT (NCT05983198) | Novartis Pharmaceuticals | 2023-11-07 |
| Consciousness, Psilocybin, and Well-Being (NCT05592379) | University of Wisconsin, Madison | 2023-11-07 |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (NCT06403436) | TOLREMO therapeutics AG | 2023-11-07 |
| A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL) (NCT05784441) | Janssen Research & Development, LLC | 2023-11-06 |
| Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL (NCT05702853) | Medical University of South Carolina | 2023-11-06 |
| A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension (NCT07036861) | Berlin-Chemie AG Menarini Group | 2023-11-06 |
| Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial (NCT06591273) | Services Institute of Medical Sciences, Pakistan | 2023-11-06 |
| AMT-253 in Patients With Selected Advanced Solid Tumours (NCT05906862) | Multitude Therapeutics (Australia) Pty Ltd | 2023-11-06 |
| The Colder Fluids - Intravenous Infusion of 10 Degrees Celsius Fluids and Its Effects on Circulation and Hemostasis (NCT06622499) | Esbjerg Hospital - University Hospital of Southern Denmark | 2023-11-06 |
| Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects (NCT06093945) | Jiangsu HengRui Medicine Co., Ltd. | 2023-11-06 |
| Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors (NCT06126406) | Chongqing Precision Biotech Co., Ltd | 2023-11-06 |
| A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection (NCT06593626) | HTA Co., Ltd. | 2023-11-06 |
| A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations (NCT06135155) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-11-06 |
| Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma (NCT05400603) | Emory University | 2023-11-06 |
| Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203) (NCT06032000) | Lemonex | 2023-11-06 |
| Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis (NCT06317688) | Texas Woman's University | 2023-11-06 |
| Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) (NCT05938465) | Exegi Pharma, LLC | 2023-11-06 |
| Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers (NCT06109259) | Daewoong Pharmaceutical Co. LTD. | 2023-11-06 |
| Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets (NCT06558032) | Dexa Medica Group | 2023-11-06 |
| Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects (NCT06111196) | Bio-Thera Solutions | 2023-11-05 |
| Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML) (NCT06125652) | Xuzhou Medical University | 2023-11-04 |
| Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais (NCT05895955) | Mahidol University | 2023-11-04 |
| TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II (NCT05848687) | Tanja Andrea Gruber | 2023-11-03 |
| A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults. (NCT05987072) | Pfizer | 2023-11-03 |
| To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers (NCT06361277) | JW Pharmaceutical | 2023-11-03 |
| A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies) (NCT06191991) | Aligos Therapeutics | 2023-11-03 |
| A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults. (NCT06105983) | Pfizer | 2023-11-03 |
| Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors (NCT05901285) | Vaxiion Therapeutics | 2023-11-02 |
| Combination Study of Antibiotics With Enzalutamide (PROMIZE) (NCT06126731) | Institute of Cancer Research, United Kingdom | 2023-11-02 |
| Clinical Study of Oncolytic Virus in Glioblastoma (NCT07145047) | Mianyang Central Hospital | 2023-11-02 |
| A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases (NCT06136884) | A2A Pharmaceuticals Inc. | 2023-11-02 |
| Study of CMAB807 Post-change in Manufacturing Site and Prolia in Healthy Volunteers (NCT06361355) | Taizhou Mabtech Pharmaceutical Co.,Ltd | 2023-11-02 |
| Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for (NCT06172387) | Tianjin Huanhu Hospital | 2023-11-01 |
| Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT (NCT06075927) | Peking University People's Hospital | 2023-11-01 |
| rTMS in Older Adults With MCI and AUD (NCT05896332) | Medical University of South Carolina | 2023-11-01 |
| Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types (NCT06034860) | Molecular Templates, Inc. | 2023-11-01 |
| A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer (NCT06095089) | Janssen Research & Development, LLC | 2023-11-01 |
| Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers (NCT05894447) | Weill Medical College of Cornell University | 2023-11-01 |
| Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate (NCT06134648) | Sanofi Pasteur, a Sanofi Company | 2023-11-01 |
| Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis (NCT05742763) | QC Kinetix LLC | 2023-11-01 |
| A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis (NCT06119529) | Eli Lilly and Company | 2023-11-01 |
| Phase I Clinical Trial of 68Ga-NOTA-SNA002 (NCT05989997) | SmartNuclide Biopharma | 2023-11-01 |
| A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers (NCT06103877) | AstraZeneca | 2023-11-01 |
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer (NCT05832892) | Shanghai Zhongshan Hospital | 2023-11-01 |
| A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old (NCT06064929) | HI-Bio, A Biogen Company | 2023-11-01 |
| Empagliflozin in ESKD - A Feasibility Study (NCT05687058) | University of Mississippi Medical Center | 2023-11-01 |
| Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases (NCT06545630) | West China Hospital | 2023-11-01 |
| Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia (NCT06082934) | Xijing Hospital | 2023-11-01 |
| A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors (NCT06248411) | Kyowa Kirin Co., Ltd. | 2023-11-01 |
| Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer (NCT06121557) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-11-01 |
| Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors (NCT06086522) | Qualigen Theraputics, Inc. | 2023-11-01 |
| A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies (NCT06066203) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-11-01 |
| First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors (NCT06134531) | Nanfang Hospital, Southern Medical University | 2023-11-01 |
| Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer (NCT07504523) | Ying Yuan, MD | 2023-11-01 |
| HRYZ-T101 Injection for HPV18 Positive Solid Tumor (NCT05952947) | HRYZ Biotech Co. | 2023-11-01 |
| Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer (NCT06093438) | Tianjin Medical University Cancer Institute and Hospital | 2023-11-01 |
| A Study of HS-10518 in Healthy Female Participants (NCT06118827) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-11-01 |
| Effectiveness of Oral Boldo in Women With Overactive Bladder (NCT06162065) | Universidad de Valparaiso | 2023-11-01 |